I wonder if the vaccine issues will actually improve the anti-viral market? Vaccines have proven to be a real cock up... both in terms of the unknowns in production and efficacy along with financial waste as billions are spent before it's known whether the virus is mild or aggressive. Surely that money spent in anti-virals, which can be stored for many years, would prove a better use of funds?
